Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the journal Human Gene ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. Here's why these two high-yield ...

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...

This transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell ...

The social campaign aimed to defy stigma, give voice to patients and care providers and pave the way for the launch of a ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Today's health news includes one woman's experience with sickle cell disease, what RFK and Trump can actually do on vaccines, ...

The Ministry of Health (MoH) has launched two landmark documents to enhance healthcare outcomes in Ghana: the National Sickle Cell Disease Strategy for 2024-2028 and the National Vaccine Policy.

Novo Nordisk’s once-a-day sickle cell disease drug etavopivat cut the rate of pain crises ... inventory write-downs and ...